Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine

In this CME-certified, on-demand Webcast of a CCO symposium at SNO 2019, a panel of expert faculty reviews and discusses the latest data on the use of tyrosine kinase inhibitors for the treatment of glioblastoma.

Tom Mikkelsen, MD, FRCPC
Program Director Manmeet S. Ahluwalia, MD, FACP Rimas V. Lukas, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: January 17, 2020 Expiration: January 16, 2021

In this downloadable slideset, Rimas V. Lukas, MD, spotlights NTRK fusions and TRK-targeted therapies for patients with GBM.

Rimas V. Lukas, MD Released: November 22, 2019

In this downloadable slideset, Manmeet S. Ahluwalia, MD, FACP, highlights regorafenib in the REGOMA trial and other multiple receptor kinase inhibitors for patients with GBM.

Manmeet S. Ahluwalia, MD, FACP Released: November 22, 2019

In this downloadable slideset, Tom Mikkelsen, MD, FRCPC, examines optimal clinical trial approaches for GBM therapies.

Tom Mikkelsen, MD, FRCPC Released: November 22, 2019